Haroon Saroona, Afzal Anoshia, Zia Shamail, Ali Syed J, Zia Fazail, Shamail Farozaan, Irfan Muhammad, Hashmi Atif A
Pathology, King's Mill Hospital - Sherwood Forest Hospitals, NHS Foundation Trust, Ashfield, GBR.
Pathology, Prince Faisal Oncology Centre, King Fahad Specialist Hospital, Buraidah, SAU.
Cureus. 2021 Mar 28;13(3):e14153. doi: 10.7759/cureus.14153.
Introduction Craniopharyngiomas (CPs) are benign neoplasms and most common suprasellar tumors. They are more frequent in children, contributing to a significant number of intracranial tumors in the pediatric population and are thought to be arising either from the epithelial remnant cells of the craniopharyngeal duct or from the adenohypophysis epithelium. Two subtypes of CPs exist, namely, adamantinomatous craniopharyngioma (ACP) and papillary craniopharyngioma (PCP). ACP is more common in children with a relatively aggressive clinical course and more frequent relapses than PCP. The study objective was to evaluate the clinicopathological features of CP in our population. Methods We conducted a retrospective observational study in the Department of Histopathology at Aga Khan Hospital, Karachi, Pakistan, over a period of 15 years, from January 2001 to December 2015. All CP cases were included in the study. A total of 207 cases were diagnosed during this period by histopathologists based on histologic features. All slides were retrieved, and diagnosis was confirmed after a reexamination of slides. Results We found that the mean age of diagnosis was 25.59±14.71 years, and the median follow-up time was 7 (3-19) years. The number of male patients was 136 (65.7%) and the number of female patients was 71 (34.3%). The most common tumor site was suprasellar (71.5%) followed by the sellar and temporal lobe (12.1% and 6.8%, respectively). The most common complaints were headache (21.7%), followed by loss of vision/decreased vision (16.4%) and vomiting (5.3%). The overall survival rate was 95.2% with a recurrence rate of 5.8%. A significant association of survival was noted with tumor recurrence. Conclusion CP is a rare brain tumor with good overall survival. We found a low recurrence rate of CP in our study. However, recurrence was found to be the most important factor determining survival in patients with CP.
引言
颅咽管瘤(CPs)是良性肿瘤,也是最常见的鞍上肿瘤。它们在儿童中更为常见,在儿童颅内肿瘤中占相当比例,被认为起源于颅咽管的上皮残余细胞或腺垂体上皮。CPs存在两种亚型,即造釉细胞瘤型颅咽管瘤(ACP)和乳头型颅咽管瘤(PCP)。ACP在儿童中更常见,临床病程相对侵袭性更强,比PCP更容易复发。本研究的目的是评估我们研究人群中CP的临床病理特征。
方法
我们在巴基斯坦卡拉奇阿迦汗医院组织病理学部门进行了一项为期15年的回顾性观察研究,时间从2001年1月至2015年12月。所有CP病例均纳入研究。在此期间,组织病理学家根据组织学特征共诊断出207例病例。所有切片均被找回,重新检查切片后确诊。
结果
我们发现诊断的平均年龄为25.59±14.71岁,中位随访时间为7(3 - 19)年。男性患者136例(65.7%),女性患者71例(34.3%)。最常见的肿瘤部位是鞍上(71.5%),其次是蝶鞍和颞叶(分别为12.1%和6.8%)。最常见的症状是头痛(21.7%),其次是视力丧失/视力下降(16.4%)和呕吐(5.3%)。总生存率为95.2%,复发率为5.8%。观察到生存率与肿瘤复发之间存在显著关联。
结论
CP是一种总体生存率良好的罕见脑肿瘤。我们的研究发现CP的复发率较低。然而,复发是决定CP患者生存的最重要因素。